Supplementary Figure S9 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

crossref（2024）

引用 0|浏览1

暂无评分

摘要

Supplementary Figure S9 shows cell viability assays of PC9, HCC827, and H1975 cells treated with VT104.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure S9 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in &lt;i&gt;EGFR&lt;/i&gt; Mutation–positive Lung Cancer